Skip to main content
OpenTrials
Completed

NCT Number: NCT01052155

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)

Completed

Looking for future studies?

Notify Me

Key information

About this study

Recruitment is indicated in patients with chronic pain management with or without controlled substance therapy.

This is a diagnostic accuracy study performed in an interventional pain management referral center in the United States.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic pain management with or without controlled substance therapy.

Exclusion criteria

None

Treatment and study plan

Urine Drug Testing

Other

LC/MS/MS Laboratory Evaluation

Other names: In-office Urine Drug Testing (Immunoassay)

Primary outcomes

  1. Diagnostic accuracy

    Time frame: 72 hours

Sponsors and collaborators

Lead sponsor

Pain Management Center of Paducah

Other

Collaborators

  • Millennium Laboratories

Registry information

Official study title

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jan 20, 2010
Registry last updated
Mar 14, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.